Pharmacists from across Europe have arrived in Dublin for the sixth annual conference of the British Thoracic Oncology Group (BTOG).
Around 400 delegates representing all disciplines in lung cancer treatment and care are meeting to highlight the disease.
Lung cancer is the most common fatal malignant disease in the world, and more than 1,800 new cases were diagnosed in Ireland in 2005, the latest date available for figures.
The overall five-year survival rate in the country is only 10%, and some 1,500 people die from the illness every year.
Radiologists, medical and clinical oncologists, thoracic surgeons, respiratory physicians, pathologists, and scientists will discuss the role of novel molecular biology technological methods in improving early diagnosis.
Giving the right treatment to patients and management of lung cancer-related symptoms will also be addressed.
The conference is being held at Clontarf Castle Hotel, and was organised by BTOG in partnership with the Irish Cancer Society, the All Ireland Lung Cancer Forum, the European Organisation for Research and Treatment of Cancer (EORTC), and the International Association for the Study of Lung Cancer (IASLC).
BTOG is a UK lung cancer and mesothelioma research group which aims to encourage the development of clinical and scientific research in all areas of thoracic oncology.
Copyright © PA Business 2008